Shop Details

Cresp 500 Product Image

Rs.29,067.50

Cresp 500

(8 customer reviews)

Cresp 500, developed by Dr Reddy’s, contains Darbepoetin Alfa 500mcg, an erythropoiesis-stimulating agent (ESA) that stimulates red blood cell production. It is used for the treatment of anemia associated with chronic kidney disease (CKD) and chemotherapy-induced anemia in cancer patients. Cresp 500 provides a vital solution for improving hemoglobin levels and enhancing overall quality of life in patients with anemia.

Brand: Dr Reddy’s Composition: Darbepoetin Alfa 500mcg

Product Introduction

Cresp 500 is an essential medication for patients suffering from anemia, particularly those with chronic kidney disease or those undergoing chemotherapy. By stimulating erythropoiesis, it helps in increasing red blood cell production, thereby improving oxygen delivery to tissues and alleviating symptoms of anemia such as fatigue and weakness.

This medication is widely used in clinical settings due to its proven efficacy and ability to improve patients' quality of life during their treatment for CKD and chemotherapy-induced anemia.

Uses of Cresp 500

Cresp 500 is primarily used for:

Cresp 500 Uses
  • Chronic Kidney Disease (CKD) Anemia – Stimulates red blood cell production to manage anemia in CKD patients.
  • Chemotherapy-Induced Anemia – Used to treat anemia in cancer patients undergoing chemotherapy.
  • Improved Hemoglobin Levels – Helps in increasing hemoglobin to combat fatigue and other symptoms of anemia.

Cresp 500 plays a vital role in improving overall health and quality of life for patients with anemia related to CKD or chemotherapy.

Side Effects of Cresp 500

Common side effects of Cresp 500 may include:

  • Headache
  • Nausea
  • Fatigue
  • Hypertension
  • Joint pain

Less Common Side Effects

Less frequent but more serious side effects may include:

  • Thromboembolic events
  • Sepsis
  • Worsening of pre-existing hypertension
  • Allergic reactions

We are pleased to offer you this product.

Cresp 500 offers a reliable and effective solution for the treatment of anemia associated with chronic kidney disease and chemotherapy. It plays a critical role in improving the quality of life for patients undergoing treatment.

  • Administered as a subcutaneous injection under the supervision of a healthcare provider.
  • Dose is adjusted based on patient response and medical condition.
  • Follow all instructions provided by your doctor regarding administration and monitoring.

Cresp 500 works by stimulating erythropoiesis through its active ingredient, Darbepoetin Alfa, which mimics the natural hormone erythropoietin, promoting the production of red blood cells and increasing hemoglobin levels.

  • Improves hemoglobin levels and alleviates symptoms of anemia.
  • Reduces the need for blood transfusions in CKD patients.
  • Effective in managing chemotherapy-induced anemia.
  • Enhances overall quality of life for patients with anemia.
  • Regular monitoring of hemoglobin levels and blood pressure is recommended.
  • Use with caution in patients with a history of cardiovascular disease.
  • Inform your healthcare provider if you experience any allergic reactions or other severe side effects.

Cresp 500 offers a proven solution for managing anemia in patients with chronic kidney disease and those undergoing chemotherapy. Always consult your healthcare provider for guidance on treatment and administration.